Liver disease accounts for two million deaths annually and is responsible for 4% of all
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …

Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the
leading causes of chronic liver disease worldwide. NAFLD and ALD share …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AI, artificial
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …

Abstract Background & Aims Diagnostic criteria for metabolic associated fatty liver disease
(MAFLD) have been proposed, but not validated. We aimed to compare the diagnostic …

Nonalcoholic fatty liver disease (NAFLD) is a heterogeneous group of liver diseases
characterized by the accumulation of fat in the liver. The heterogeneity of NAFLD is reflected …

Context In 2020, the terminology of metabolic dysfunction–associated fatty liver disease
(MAFLD) was proposed to replace nonalcoholic fatty liver disease (NAFLD). Objectives This …

Objectives Liver disease is a leading cause of premature death, partly driven by the
increasing incidence of non-alcohol-related fatty liver disease (NAFLD). Many people with a …

The epidemiology and the current burden of chronic liver disease are changing globally,
with non-alcoholic fatty liver disease (NAFLD) becoming the most frequent cause of liver …

Cholesterol synthesis occurs in almost all cells, but mainly in hepatocytes in the liver.
Cholesterol is garnering increasing attention for its central role in various metabolic …

Alcohol-associated liver disease (ALD) is the most common cause of advanced hepatic
disease and frequent indication for liver transplantation worldwide. With harmful alcohol use …